Literature DB >> 22311063

Myasthenia gravis and endurance exercise.

Bernd Volker Scheer1, Encarna Valero-Burgos, Ricardo Costa.   

Abstract

This is the first report of a runner with myasthenia gravis who completed an ultra endurance event. Myasthenia gravis, a neuromuscular disease that usually results in skeletal muscle weakness, which worsens with exercise and strenuous aerobic exercise, is generally contraindicated. Our runner completed a 220-km, 5-day ultramarathon and presented with various symptoms including muscular skeletal weakness, cramps, generalized fatigue, unintelligible speech, involuntary eye and mouth movements, problems swallowing, food lodging in his throat, and problems breathing. Risk factors identified for exacerbations are running in extreme temperatures, prolonged runs (especially a distance of 30 km or more), running uphill, lack of sleep, and stress. The medical team was in the novel situation to look after a runner with myasthenia gravis and needed to be aware of the patient's condition, symptoms, and risk factors to safely care for him.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311063     DOI: 10.1097/PHM.0b013e31824663c6

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  5 in total

1.  Recommendations on Youth Participation in Ultra-Endurance Running Events: A Consensus Statement.

Authors:  Volker Scheer; Ricardo J S Costa; Stéphane Doutreleau; Beat Knechtle; Pantelis T Nikolaidis; William O Roberts; Oliver Stoll; Adam S Tenforde; Brian Krabak
Journal:  Sports Med       Date:  2021-03-11       Impact factor: 11.136

Review 2.  Recommendations on the Appropriate Level of Medical Support at Ultramarathons.

Authors:  Martin D Hoffman; Morteza Khodaee; Nikiah G Nudell; Andrew Pasternak
Journal:  Sports Med       Date:  2020-05       Impact factor: 11.136

3.  The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial.

Authors:  Simone Birnbaum; Jean-Yves Hogrel; Raphael Porcher; Pierre Portero; Bernard Clair; Bruno Eymard; Sophie Demeret; Guillaume Bassez; Marcela Gargiulo; Estelle Louët; Sonia Berrih-Aknin; Asmaa Jobic; Philippe Aegerter; Philippe Thoumie; Tarek Sharshar
Journal:  Trials       Date:  2018-01-18       Impact factor: 2.279

4.  The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study.

Authors:  Elisabet Westerberg; Carl Johan Molin; Sören Spörndly Nees; Johan Widenfalk; Anna Rostedt Punga
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  Marathons and myasthenia gravis: a case report.

Authors:  Simone Birnbaum; Tarek Sharshar; Bruno Eymard; Marie Theaudin; Pierre Portero; Jean-Yves Hogrel
Journal:  BMC Neurol       Date:  2018-09-18       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.